Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:e160
doi: 10.1161/ATVBAHA.108.172072
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klevay, L. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Klevay, L. M.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:e160.)
© 2008 American Heart Association, Inc.


Letters to the Editor

Homocysteine Is Not So Paradoxical

Leslie M. Klevay

Departments of Internal Medicine, and of, Department of Pharmacology, Physiology, and Therapeutics, University of North Dakota, School of Medicine and Health Sciences


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

To the Editor:

Rodionov and Lentz1 summarized the homocysteine paradox. Hyperhomocysteinemia disrupts vascular structure and function in animals and predicts risk of "coronary events, stroke, venous thromboembolism, and death," yet clinical benefit in intervention trials remains unproved. They offer several plausible explanations.

Trials usually involve dietary supplementation with folate and vitamins B-6 and B-12. It also seems plausible that results would have been better if the intervention trials included copper.

High homocysteine concentrations lead to increased homocysteine thiolactone,2 an irreversible inhibitor of lysyl oxidase3 which depends on copper to initiate the cross-linking of collagen and elastin in arteries.4 Insufficient lysyl oxidase leads to vascular disease.4 Thus decreasing homocysteine may not lead to vascular repair without extra copper which also can lower plasma homocysteine.5

The Western diet is often low in copper6 according to pooled data from several articles on more than 900 adult diets chemically analyzed. Sixty-two percent and 36% of diets of 80 randomly selected adults in Baltimore7 were below the recommended dietary allowance and the estimated average requirement for adults, 0.9 and 0.7 mg daily, respectively.8 Diets low in copper tend to be low in folate as well and vice versa.9

Copper deficiency is the only nutritional insult that elevates cholesterol, blood pressure, homocysteine, isoprostanes, and uric acid, has adverse effects on electrocardiograms and arteries, impairs glucose tolerance and paraoxonase activity, and promotes thrombosis and oxidative damage. More than 80 anatomic, chemical, and physiological similarities between animals deficient in copper and people with ischemic heart disease have been . . . [Full Text of this Article]